Bleeding within the brain, or intracerebral hemorrhage, was associated with a high risk of developing dementia post stroke, according to research presented at the American Stroke Association's International Stroke Conference 2016.
Intracerebral hemorrhage, which results from a weakened vessel that ruptures and bleeds into the brain, represents 13 percent of all strokes. Researchers studied how often and why dementia might occur after intracerebral hemorrhage by following a population of 218 intracerebral stroke patients, who were free of dementia in the first six months after stroke.
They found:
20 percent had developed dementia at one year after stroke.
63 patients developed new onset dementia during an average follow-up of 5.4 years.
Risk factors associated with a higher risk of dementia after intracerebral hemorrhage, included the location of the brain bleed, older age, history of a previous stroke or transient ischemic attack, higher stroke severity score and recurrent stroke during the follow-up.
Risk factors identified on brain imaging were particularly linked with a very frequent cause of bleeding strokes called cerebral amyloid angiopathy.
Doctors caring for stroke survivors should consider dementia risks, especially when risk factors are present, researchers said.
###
Additional Resources:
Any available multimedia related to these tips are on the right column of this link http://newsroom.heart.org/news/isc-16-wednesday-news-tips?preview=0a5ba41ae6d06babec5f52bf7f717541
Stroke Caregiver Resources
Emotional and Behavioral Conditions After Stroke
Join the AHA/ASA Support Network to talk with others going through similar journeys including depression after stroke.
Follow news from the American Stroke Association's International Stroke Conference 2016 via Twitter: @HeartNews #ISC16.
Statements and conclusions of study authors that are presented at American Stroke Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.